This webinar was given in 2026 by Dr. Julie M. Eggington (CGI's co-founder and CEO) and Dr. Leeza Osipenko (Consilium Scientific's founder and CEO). It was titled "Tested or Trusted? The Evidence Gap at the Heart of Diagnostic Evidence". Using real-world examples, this seminar highlights how tests can be widely used — and billed — even when evidence is incomplete.
This webinar was given in 2024 by CGI's co-founder and CEO, Dr. Julie M. Eggington, to Stanford University's METRICS International Forum. It was titled "Reality Checking Clinical Genetics and Genomics: A review of the emerging data that demonstrates that faulty assumptions and sloppy clinical lab work pervade 'Precision Medicine' in the USA".
RETURNING IN THE FALL OF 2026: TestWisely.org
TestWisely is an educational resource to aid in the selection of high quality hereditary cancer tests. The project was initially funded by the Utah Department of Health through a CDC grant.